These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10453948)

  • 1. Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.
    Matsumura M; Shiratori Y; Niwa Y; Tanaka T; Ogura K; Okudaira T; Imamura M; Okano K; Shiina S; Omata M
    J Hepatol; 1999 Aug; 31(2):332-9. PubMed ID: 10453948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
    Witzigmann H; Geissler F; Benedix F; Thiery J; Uhlmann D; Tannapfel A; Wittekind C; Hauss J
    Surgery; 2002 Jan; 131(1):34-43. PubMed ID: 11812961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis.
    Jin J; Niu X; Zou L; Li L; Li S; Han J; Zhang P; Song J; Xiao F
    Cancer Lett; 2016 Aug; 378(1):33-7. PubMed ID: 27160647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma.
    Gross-Goupil M; Saffroy R; Azoulay D; Precetti S; Emile JF; Delvart V; Tindilière F; Laurent A; Bellin MF; Bismuth H; Debuire B; Lemoine A
    Ann Surg; 2003 Aug; 238(2):241-8. PubMed ID: 12894018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
    Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
    Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
    Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation.
    Wong IH; Yeo W; Leung T; Lau WY; Johnson PJ
    Cancer Lett; 2001 Jun; 167(2):183-91. PubMed ID: 11369140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.
    Kong SY; Park JW; Kim JO; Lee NO; Lee JA; Park KW; Hong EK; Kim CM
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1091-8. PubMed ID: 19184104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Marubashi S; Dono K; Sugita Y; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    Transplant Proc; 2006 Dec; 38(10):3640-2. PubMed ID: 17175354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.
    Minata M; Nishida N; Komeda T; Azechi H; Katsuma H; Nishimura T; Kuno M; Ito T; Yamamoto Y; Ikai I; Yamaoka Y; Fukuda Y; Nakao K
    J Gastroenterol Hepatol; 2001 Apr; 16(4):445-51. PubMed ID: 11354284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
    Ijichi M; Takayama T; Matsumura M; Shiratori Y; Omata M; Makuuchi M
    Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
    Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
    Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.